71 |
Strukturelle und funktionelle Anpassung des Ubiquitin-Proteasomsystems an IFN-gammaRieger, Melanie 16 February 2009 (has links)
Das Ubiquitin-Proteasom-System ist an der Degradation cytosolischer Proteine und der Generierung von Antigenen beteiligt, die über MHC Klasse I Moleküle CD8+ T Zellen präsentiert werden. Die Antigenprozessierung wird durch Typ I und II Interferone beeinflusst, welche die Formierung des Immunoproteasoms und des Proteasomen-Aktivators PA28 induzieren und so die katalytische Aktivität des Ubiquitin-Proteasom-Systems qualitativ verändern. In der vorliegenden Arbeit wurde im Zellkulturmodell unter dem Einfluss von IFN gamma die zunehmende Inkorporation der Immunountereinheiten in de novo assemblierende 20S Proteasomen und die daraus resultierende Veränderung der proteolytische Aktivität untersucht. Die Inkorporation der Immunountereinheiten wurde mittels 2D Gelelektrophorese und Western Blots von 20S Proteasomen untersucht, die nach unterschiedlicher Stimulationsdauer mit IFN gamma aus HeLa Zellen isoliert wurden. Es konnte gezeigt werden, dass innerhalb der ersten 24h einer IFN gamma Stimulation die strukturelle Heterogenität des zellulären Proteasomenpools zunimmt, indem sowohl intermediäre als auch Immunoproteasomen assemblieren. In der Nativ-PAGE von Lysaten IFN gamma stimulierter Zellen wurde eine Zunahme des 20S Proteasoms als freier Komplex und in Assoziation mit PA28 beobachtet, während die Menge des zum ATP-abhängigen Abbau von polyubiquitinierten Proteinen notwendigen 26S Proteasoms unverändert blieb. Die Stimulation mit IFN gamma hatte eine Steigerung der gesamtproteasomalen Aktivität zur Folge, die unter Inhibition der Interaktion zwischen 20S Proteasom und PA28 verzögert erfolgte. Die katalytischen Eigenschaften isolierter Proteasomen wurden anhand der Generierung eines immunrelevanten Hepatitis C CTL Epitops des viralen Core Proteins in vitro untersucht. Im Verlauf der IFN gamma Stimulation de novo assemblierte Proteasomen wiesen jeweils unterschiedliche Präferenzen für die Generierung des untersuchten CTL Epitops auf. Eine weitere, proteasomen-spezifische Änderung der katalytischen Aktivität bewirkte die Assoziation des Proteasomen-Aktivators. Innerhalb der ersten zwölf Stunden einer IFN gamma Stimulation wurde das Epitop vermehrt mit der Unterstützung des Proteasomen-Aktivators generiert, nach 24 Stunden zunehmend durch freies 20S Proteasom. Die Ergebnisse der vorgestellten Arbeit zeigen, dass Strukturvarianten des Proteasoms zusammen mit PA28 redundant funktionieren und eine hohe proteolytische Plastizität des UPS gewährleisten. / The ubiquitin proteasome system is responsible for the degradation of cytosolic proteins and the processing of MHC class I restricted antigens. The generation of these antigens is influenced by type I and II interferons which induce the expression of immunoproteasomes and the proteasome activator PA28; and thereby impact the quality of peptides processed by the proteasome system. The adoption of the proteasome system to a proinflammatory environment has been investigated in a cell culture model by isolating proteasomes after different stages of IFN gamma stimulation. The composition of isolated proteasomes was analysed by 2D PAGE and western blot approach. The presented work shows that within 24h of IFN gamma stimulation an increasing heterogeneity of the cellular proteasome pool is observed, resulting from the assembly of both intermediate type proteasomes and immunoproteasomes at the early stage of IFN gamma stimulation. It could be shown by native PAGE of HeLa cell lysates that IFN gamma induces increasing amounts of 20S proteasomes and PA28 associated proteasomes without decreasing the amount of 26S proteasomes that are necessary for the ATP dependent degradation of ubiquitinated proteins; and resulting in an enhanced total proteasomal activity in vitro. This increase in activity was delayed when the interaction of 20S proteasomes and PA28 was inhibited. A comparative analysis of the ability of isolated 20S proteasomes to generate a known hepatitis C virus derived CTL epitope in vitro proved that during early IFN gamma stimulation de novo assembled proteasomes exhibited a structure specific preference to generate the HCV CTL epitope either alone or in combination with the proteasome activator PA28. Within the first 12h of IFN gamma stimulation the epitope was generated with higher efficiency by 20S proteasomes in association with PA28, whereas after 24h the impact of PA28 on the proteasome pool was less pronounced. The presented work shows that IFN gamma induces a heterogeneity of 20S proteasomes in the early stage of stimulation, acting in combination with the proteasome activator in a redundant manner; and provides a high proteolytic placticity of the proteasome system.
|
72 |
Phenotypic and functional characterization of cytotoxic T lymphocytes in HIV-1 infected South African adultsPillay, Santhoshan Thiagaraj 12 1900 (has links)
Bibliography / Thesis (MScMedSc (Pathology. Medical Virology))--University of Stellenbosch, 2010. / ENGLISH ABSTRACT: In just 25 years since the first reported cases in 1981, the number of Human
Immunodeficiency virus (HIV) infected people has risen to 65 million, and over 25
million have died of acquired immunodeficiency syndrome (AIDS). Sub-Saharan Africa
accounts for 67% of all people living with HIV and 72% of deaths in this region were
AIDS related. Tuberculosis (TB) is one of the most common opportunistic infections in
AIDS patients, particularly in developing countries, where 60 - 70% of TB cases occur
in HIV-1-infected persons. HIV-1 is a high risk factor for the development of TB, the
reactivation of a latent Mycobacterium tuberculosis infection and also progressive TB.
CD8+ Cytotoxic T Lymphocytes (CTL) are pivotal in the host immune response to HIV
infection. CTL are associated with resolution of acute infection and with reduction in
viral load. Studies in macaques and humans indicate the importance of CTL in the
control of HIV infection, where reduction in CD8+ T cell number has been correlated
with progression to AIDS.
The current study was a cross-sectional descriptive study of CD8+ T cells of HIV+ adult
South Africans with and without TB co-infection (TB disease). The cohort consisted of
anti-retroviral therapy (ART) naive patients and all CTL analyses were carried out on
peripheral blood mononuclear cells (PBMCs). A total of 60 South African adults from the
Western Cape were utilized in this study, including 15 healthy controls; 30 HIV+TB-individuals
and 15 HIV+TB+ individuals. Expression of phenotypic, activation and
functional markers were investigated by flow cytometry with the use of fluorochomeconjugated
antibodies. The markers examined included the novel activation marker
CD137, the CTL associated markers Perforin, Granzyme A, CD107a/b, Fas (CD95),
and FasL (CD95L), intracellular cytokines IFN-y and TNF-a and the chronic HIV CTL
dysfunction marker PD-1. HIV infection alone was associated with increased baseline expression of TNF-a,
Perforin, Granzyme A, PD-1, Fas (CD95), and FasL (CD95L), but not CD137(4-1BB) or
IFN-y as compared to uninfected controls. TB co-infection resulted in further increased
baseline expression of TNF-a, perforin, PD-1, FasL (CD95L), as well as increased IFN-y. HIV-1 antigen (gag)-specific stimulation in vitro indicated that in HIV infection was
associated with antigen-specific upregulation of activation and cytotoxicity markers
CD137, IFN-y, TNF-a, Fas, FasL and CD107a/b. In TB co-infection a reduction in
antigen-specific degranulation (CD107a/b up-regulation) and also Fas and FasL
expression was observed.
TB co-infection (in the form of active pulmonary TB) reduced antigen-specific CTL
functional activity, but simultaneously there was an association with increased baseline
PD-1 expression and also cytolytic marker expression (Fas, FasL, TNF-a). These
cytolytic markers could be involved in non-antigen-specific bystander target cell death.
The expression of the co-stimulatory molecule CD137 appeared to correlate with
interferon-y production and levels of degranulation, confirming its usefulness as a
putative surrogate marker of functional responsiveness. These data indicate that in
addition to impacting on CD4 T cell function, TB co-infection leads to higher baseline
expression of CTL-associated markers, but to dysfunctional antigen-specific CTL
responses. / AFRIKAANSE OPSOMMING: Slegs vyf en twintig jaar na die eerste berigte van die menslike immuniteitsgebrekvirus
(MIV) in 1981, het die getal MIV-geinfekteerde individue gestyg tot 65 miljoen en het
meer as 25 miljoen mense alreeds gesterf aan die verworwe immuniteitsgebrek
sindroom (VIGS). Sub Sahara Afrika maak 67% uit van alle HIV gevalle en het `n MIVverwante
doodsyfer van 72%. Een van die algemeenste opportunistiese infeksies in
VIGS pasiente is Tuberkulose (TB). In ontwikkelende lande, veral, kom 60-70% van TB
gevalle voor in MIV-1 geinfekteerde individue. MIV-1 is `n hoe risiko faktor vir die
ontwikkeling van TB, die heraktivering van latente Mycobacterium tuberculosis infeksie
en progressiewe TB.
Die CD8+ sitotoksiese T Limfosiete (STL) se immuun reaksie teen `n MIV infeksie is
noodsaaklik en word geassosieer met `n resolusie van die akute infeksie en `n afname
in viruslading. Studies in die mens en macaque het getoon dat sitotoksiese T limfosiete
belangrik is vir die beheer van MIV infeksies aangesien die afname in CD8+ sel getalle
korreleer met die verloop tot VIGS.
Hierdie deursnit-beskrywende studie het die CD8+ T selle van MIV+ volwasse Suid-Afrikaners, met of sonder`n TB mede-infeksie, ondersoek. STL analise is gedoen op die
perifere bloed mono-nuklere selle (PBMS) van pasiente wat geen teen-retrovirale
terapie (TRT) ontvang het nie. `n Totaal van sestig Suid-Afrikaanse volwassenes van
die Wes-Kaap het deelgeneem aan die studie wat 15 gesonde kontroles; 30 MIV+TBen
15 MIV+TB+ individue ingesluit het. Die uitdrukking van fenotipiese, aktiverings en
funksionele merkers is ondersoek deur middel van vloeisitometrie en fluorochroomgekonjugeerde
teenliggaampies. Laasgenoemde het ingesluit die nuwe
aktiversingsmerker CD 137, die STL geassosieerde merkers Perforien en Gransiem A,
CD 107a/b, Fas (CD95) en FasL (CD95L), intrasellulere sitokiene IFN-y en TNF-a en
PD-1, die merker vir chroniese MIV CTL disfunksie. Daar is gevind dat `n TB mede-infeksie (in die vorm van aktiewe pulmonere TB) die
antigeen-spesifieke STL funksie verlaag en terselftertyd `n verhoging in die uitdrukking
van PD-1 en sitolitiese merkers (Fas, FasL, TNF-a) bewerkstellig. Hierdie sitolitiese
basislyn merkers is moontlik betrokke by die dood van nie-antigeen-spesifieke
omstander teiken selle. Die uitdrukking van die mede-stimulatoriese molekule CD 137
blyk om te korreleer met die produksie van STL IFN-y en die vlakke van degranulasie.
Dit bevestig die merker se bruikbaarheid as `n gewaande surrogaat merker vir
funksionele reaksies. Die data toon verder dat `n TB mede-infeksie nie net `n effek het
op die CD4 T sel funksie nie, dit lei ook tot `n verhoogde basislyn uitdrukking van STLgeassosieerde
merkers, maar met disfunksionele antigeen-spesifieke STL reaksies.
Hierdie studie het bepaal dat `n MIV infeksie verbind word met `n toename in die
basislyn uitdrukking van TNF-a, Perforien, Gransiem A, PD-1, Fas (CD95) en FasL
(CD95L). Dit is egter nie die geval wanneer die uitdrukking van CD 137 (4-1BB) of IFN-y
vergelyk word met nie-geinfekteerde kontroles. `n TB mede-infeksie het `n verdere
toename in die uitdrukking van TNF-a, Perforien, PD-1, FasL (CD95L) getoon, asook `n
verhoging in IFN-y vanaf die basislyn. In vitro MIV-1 antigeen (gag)-spesifieke
stimulasies het aangedui dat `n MIV infeksie met die antigeen-spesifieke op-regulasie
van aktiverings en sitotoksiese merkers CD137, IFN-y, TNF-a, Fas, FasL en CD107a/b
geassosieer word. In `n TB mede-infeksie, is `n verlaging van antigeen-spesifieke
degranulasie (CD 107a/b op-regulasie) asook die uitdrukking van Fas en FasL
waargeneem. / The Poliomyelitis Research Foundation / The National Health Laboratory Service
|
73 |
Étude des effets de l’initiation précoce du traitement sur la réactivité immunitaire chez l’enfant infecté par le VIH-1Dieumegard, Hinatea 08 1900 (has links)
De nombreuses études ont montré que les enfants traités précocement ne sont pas capables de développer une réponse à médiation cellulaire contre le VIH [1]. Cependant, le rebond viral observé après la rémission prolongée du cas du « bébé du Mississippi » pose de nombreuses questions quant à la capacité de ces enfants à développer une réponse immunitaire VIH spécifique malgré une suppression virale à long terme [2, 3]. Nous avons étudié cinq cas ayant un profil similaire au « bébé du Mississippi » qui ont été identifiés précédemment [4].
L’objectif de ce projet était de déterminer si les enfants traités précocement développent une réponse immunitaire à médiation cellulaire contre le VIH qui est quantitativement et/ou qualitativement différente de celle retrouvée chez les enfants traités plus tard.
Cette étude a permis de montrer que l’amplitude et la diversité des réponses LTC des enfants traités précocement est plus faible que celle observée chez des enfants traités plus tard ou non traités. / Several studies have shown early treated children are not able to develop a cell-mediated response [1]. However, the viral rebound after prolonged remission in the case of the "Mississippi baby" raises many questions about the ability of these children to develop a specific immune response despite HIV viral suppression in the long term [2, 3]. We currently have five cases with a similar profile to the "Mississippi baby" that were identified previously [4].
The objective of this project is to determine whether early treated children develop an immune cell-mediated response against HIV that is quantitatively and/or qualitatively different from that found in children treated later.
This study showed that the magnitude and diversity of CTL responses of children treated early is lower than that observed in children treated later if possible.
|
74 |
L’impact de la grossesse sur l’amplitude et la diversité de la reconnaissance antigénique des lymphocytes T cytotoxiques dirigés contre le VIH-1Jolette, Elyse 09 1900 (has links)
La transmission mère-enfant (TME) du VIH-1 est un des enjeux majeurs de la pandémie. Une meilleure compréhension de la réponse des lymphocytes T cytotoxiques CD8+ (LTC) VIH-spécifiques lors de la grossesse facilitera le design de stratégies optimales pour diminuer la TME. Notre objectif est donc de caractériser l’amplitude et la diversité de la reconnaissance antigénique des LTC VIH-spécifiques avant, pendant et après la grossesse chez des femmes infectées par le VIH-1. Nos résultats montrent pour la première fois que l’initiation et la progression de la grossesse, à elles seules, n'ont que peu d’influence sur l’amplitude et la diversité de la reconnaissance antigénique des réponses LTC en termes de production d’IFN‐. Ces résultats indiquent que les femmes infectées par le VIH conservent une immunocompétence durant leur grossesse, du moins dans le contexte d’un traitement antirétroviral efficace. Ceci pourrait éventuellement aider à promouvoir l’immunisation comme stratégie pour prévenir la TME du VIH‐1. / Mother-to-child transmission (MTCT) of HIV-1 is one of the major issues of the pandemic. Characterization of HIV-specific immunity during pregnancy, especially cytotoxic CD8+ T lymphocytes (CTL), will lead to a better understanding of HIV pathogenesis and facilitate design of optimal strategies to prevent MTCT. Our objective is to describe the magnitude and the breadth of antigen recognition of HIV-specific CTL responses before, throughout and after pregnancy in a group of HIV-infected women. Our results revealed for the first time that initiation of pregnancy by itself doesn’t change the magnitude of CTL responses in terms of IFN- production. These findings support the fact that HIV-infected women maintain immunocompetence throughout gestation, at least in the context of effective antiretroviral treatment. These results provide a novel understanding of the dynamics of HIV-specific CTL responses during pregnancy and may help to promote maternal immunization as a strategy to prevent MTCT of HIV-1.
|
75 |
Controller-Synthese für Services mit DatenBathelt-Tok, Franziska 12 December 2017 (has links)
Die steigende Nachfrage an immer komplexeren Systemen in verschiedensten wirtschaftlichen Bereichen, erfordert Strategien, die Wartbarkeit und Wiederverwendbarkeit unterstützen. An diesem Punkt setzen service-orientierte Architekturen (SOAn) an. Dieses Paradigma fordert die Aufspaltung von Funktionalität in Services, die komponiert werden können, um eine gewünschte, komplexe Funktionalität zu erreichen. Besonders in sicherheitskritischen Bereichen, kann eine fehlerbehaftete Komposition jedoch zu hohen finanziellen Einbußen oder sogar zu lebensbedrohlichen Situationen führen. Um die Korrektheit sicherzustellen, müssen Kompositionsmethoden im Vorfeld definierte Eigenschaften garantieren und die, durch die unabhängige Entwicklung auftretenden, Interface-Inkompatibilitäten behandeln. Existierende Ansätze zur automatisierten Service-Komposition durch Controller-Synthese beinhalten jedoch keine formale Datenbehandlung und können daher nicht mit datenabhängigem Verhalten umgehen.
In der vorliegenden Arbeit, löse ich dieses Problem durch die Bereitstellung eines Ansatzes zur automatisierten Synthese datenabhängiger, korrekter Service-Controller. Dabei wird ein Controller direkt aus den spezifizierten Anforderungen und dem Verhalten der Services erzeugt.
Basierend auf den Annahmen, dass die Anforderungen in RCTL, einer Untermenge der Computational Tree Logic (CTL), spezifiziert und die Services als Algebraische Petrinetze (APNe) gegeben sind, vereinigt mein neuartiger Ansatz die beiden Formalismen und unterstützt eine zuverlässige Extraktion des Controller-Verhaltens. Durch die Nutzung der APNe, erlaubt der Ansatz eine formale Datenbehandlung und somit eine Betrachtung datenabhängigen Verhaltens.
Die Anwendbarkeit meines Ansatzes habe ich an drei Fallstudien aus dem medizinischen Bereich gezeigt, wo Geräte sicher miteinander kommunizieren müssen. / The continuously increasing demand for more complex systems in various economical domains requires a strategy that supports maintainability and reusability. This is addressed by the service-oriented architecture (SOA)}-paradigm that encourages the encapsulation of functionality into services. To achieve a specific functionality, services can be composed. Especially in safety-critical systems, an incorrect composition of various components can lead to high financial losses or even life threatening situations. To ensure the correctness, composition methods must particularly be able to guarantee pre-specified requirements and to overcome interface incompatibilities, which result from the independent development of the single services. However, current approaches for automated service composition via controller synthesis do not support a formal data-treatment and do not cope with data-dependent behavior.
In this thesis, we overcome this problem by providing an approach for the automated synthesis of data-dependent service controllers that are correct-by-construction. The core idea is to synthesize such a controller directly from given requirements and the behavior of the services. Based on the assumptions that the requirements are specified using a subset of Computational Tree Logic (CTL), called RCTL, and that the services are given as algebraic Petri Nets (APNs), our novel synthesis process unifies the two formalisms and enables a reliable extraction of the controller behavior. Especially due to the use of APNs, our approach supports a formal data-treatment and enables a consideration of data-dependent behavior.
With our synthesis process, which is based on a successive combination of requirements and services, we provide a practical applicable approach that works fully automatically. We show the applicability of our approach using three case studies in which medical devices interact with each other.
|
76 |
Periodic solutions and bistability in a model for cytotoxic T-lymphocyte (CTL) response to human T-cell lymphotropic virus type I (HTLV-I)Lang, John Cameron 11 1900 (has links)
HTLV-I is the first discovered human retrovirus and a causative agent of both adult T-cell leukemia (ATL) and HTLV-I-associated myelopathy (or tropical spastic paraparesis) (HAM/TSP). Previous models have been successful in providing insight into the progression of HTLV-I infection. The relative simplicity of HTLV as well as its similarities to HIV and other diseases allow HTLV-I research to have diverse applications.
The development of HAM/TSP is precipitated by a CTL immune response. Previous models for CTL response to HTLV-I infection have had relatively simple behaviours. A novel sigmoidal CTL response function results in complex behaviours previously unobserved. We establish the existence of bistability between solutions corresponding to carrier and endemic states. In addition, both super- and sub-critical Hopf bifurcations as well as the resulting stable and unstable periodic solutions are observed. Analytical and numerical results are discussed, as well as the biological consequences of the aforementioned behaviours. / Applied Mathematics
|
77 |
THE CRITICAL ROLE OF CD4+ TH CELLS IN CD8+ CTL RESPONSES AND ANTI-TUMOR IMMUNITY2012 April 1900 (has links)
The goal of this body of research was to elucidate the mechanism by which CD4+ T cells provide help for CD8+ cytotoxic T lymphocyte (CTL) responses in different immunization types. The establishment of diseases, such as chronic infections and cancers, is attributed to severe loss of or dysfunctions of CD4+ T cells. Even in acute infections, CD4+ T cell deficiency leads to poor memory responses. While the role of CD4+ T cells is being increasingly appreciated in these diseases, the timing and nature of CD4+ T help and associated molecular mechanisms are not completely understood. Growing evidence suggests that, depending on the type of infections or immunizations, the requirements of CD4+ T cells can vary for optimal CD8+ CTL responses. In order to understand the modulatory effects of CD4+ T cells for optimal CD8+ CTL responses, two distinct immunization types were chosen. These include: 1) non-inflammatory dendritic cell (DC) immunization, which fails to provide inflammatory/danger signals; and 2) inflammatory adenovirus (AdV) immunization, which provides profound inflammatory/danger signals. This allowed us to study CD4+ T cell’s participation under different inflammatory conditions.
The studies described in Chapters 2 and 3 of this thesis were performed to further understand the concept of how CD4+ T cells mediate optimal CD8+ CTL responses. This has been called the “new dynamic model of CD4+ T helper – antigen (Ag)-presenting cells (Th-APCs),” proposed in 2005 by our laboratory. The study described in Chapter 2 shows that Th-APCs participate not only in augmenting CTL-mediated immune responses, perhaps during early phase, but also in regulating cellular immunity, perhaps during a later phase. Through enhanced IL-2, CD80 and CD40L singnaling, and weaker peptideMHC I (pMHC) signaling, Th-APCs stimulated naïve CD8+ T cells to differentiate into effector CTLs, capable of developing into, central memory CTLs. Th-APC-stimulated CD4+ T cells behaved like Th cells in function, augmenting the overall magnitude of CTL responses. In contrast, Th-APCs were able to kill DCs and other Th-APCs, predominantly through perforin-mediated pathway. The experiments described in Chapter 3 revealed a novel co-operative role of cognate Th-CTL interactions, contrary to previously known immune-regulatory mechanisms among Th-Th or CTL-CTL interactions. In our experiments, Th cells, via CD40L, IL-2, and acquired pMHC-I signaling, enhanced CTL survival and transition into functional memory CTLs. Moreover, RT-PCR, flow cytometry and western blot analysis demonstrate that increased survival of Th cell-helped CTLs is matched with enhanced Akt1/NF-κB activation, down-regulation of FasL and TRAIL, and altered expression profiles with up-regulation of prosurvival (Bcl-2) and down-regulation of proapoptotic (NFATc1, Bcl-10, Casp-3, Casp-4, Casp-7) genes/ molecules. Finally, helped CTLs were also able to induce protection against highly metastasizing tumor challenge, explaining why memory CTLs generated under cognate Th1’s help show survival and recall advantages.
The studies in Chapter 4 showed how the precursor frequency (PF) of CD8+ T cells impacts CD4+ T helper requirements for functional CTL responses. At endogenous PF, CD4+ T helper signals were necessary for both primary and memory CTL responses. At increased PF, CD4+ T help, and its CD40L but not IL-2 signal became dispensable for primary CTL responses. In contrast, memory CTL responses required CD4+ T cell signals, largely in the form of IL-2 and CD40L. Thus, these results could impact the development of novel immunotherapy against cancers, since their efficacy would be determined in part by CD4+ T help and CD8+ T cell PF.
Finally, the study showed the importance of CD4+ T cells for multiple phases of AdV transgene product-specific CTL responses. These include: a) cognate CD4+ T cells enhanced CTL responses via IL-2 and CD40L signaling during primary, maintenance and memory phases; b) polyclonal CD4+ T environment enhanced the survival of AdV-specific CTL survival, partially explaining protracted CTL contraction phase; and c) during the recall phase, the CD4+ T environment, particularly memory CD4+ T cells, considerably enhanced not only helped, but also unhelped, memory CTL expansion. Thus, these results suggest the participation of both cognate and polyclonal CD4+ T cells for multiple phases of AdV-specific CTLs.
Taken together, the current work delineated the critical roles of CD4+ T cells in different stages of CTL responses and in the development of anti-tumor immunity. The results presented here will significantly advance our current understanding of immunity to cancers, autoimmunity and chronic infections, since pathogenesis of these diseases is largely determined by CD4+ T helper functions. As most immunization procedures use the principle that is based on functions of memory cells, the knowledge gained from this work will also have a major impact on designing vaccines against intractable diseases, including cancers and chronic infections. Moreover, in advanced tumors, vaccines developed using this knowledge may act synergistically with other cancer treatments such as irradiation, chemotherapy and microsurgery, minimizing their side effects and prolonging the lives of patients.
|
78 |
L’impact de la grossesse sur l’amplitude et la diversité de la reconnaissance antigénique des lymphocytes T cytotoxiques dirigés contre le VIH-1Jolette, Elyse 09 1900 (has links)
La transmission mère-enfant (TME) du VIH-1 est un des enjeux majeurs de la pandémie. Une meilleure compréhension de la réponse des lymphocytes T cytotoxiques CD8+ (LTC) VIH-spécifiques lors de la grossesse facilitera le design de stratégies optimales pour diminuer la TME. Notre objectif est donc de caractériser l’amplitude et la diversité de la reconnaissance antigénique des LTC VIH-spécifiques avant, pendant et après la grossesse chez des femmes infectées par le VIH-1. Nos résultats montrent pour la première fois que l’initiation et la progression de la grossesse, à elles seules, n'ont que peu d’influence sur l’amplitude et la diversité de la reconnaissance antigénique des réponses LTC en termes de production d’IFN‐. Ces résultats indiquent que les femmes infectées par le VIH conservent une immunocompétence durant leur grossesse, du moins dans le contexte d’un traitement antirétroviral efficace. Ceci pourrait éventuellement aider à promouvoir l’immunisation comme stratégie pour prévenir la TME du VIH‐1. / Mother-to-child transmission (MTCT) of HIV-1 is one of the major issues of the pandemic. Characterization of HIV-specific immunity during pregnancy, especially cytotoxic CD8+ T lymphocytes (CTL), will lead to a better understanding of HIV pathogenesis and facilitate design of optimal strategies to prevent MTCT. Our objective is to describe the magnitude and the breadth of antigen recognition of HIV-specific CTL responses before, throughout and after pregnancy in a group of HIV-infected women. Our results revealed for the first time that initiation of pregnancy by itself doesn’t change the magnitude of CTL responses in terms of IFN- production. These findings support the fact that HIV-infected women maintain immunocompetence throughout gestation, at least in the context of effective antiretroviral treatment. These results provide a novel understanding of the dynamics of HIV-specific CTL responses during pregnancy and may help to promote maternal immunization as a strategy to prevent MTCT of HIV-1.
|
79 |
Periodic solutions and bistability in a model for cytotoxic T-lymphocyte (CTL) response to human T-cell lymphotropic virus type I (HTLV-I)Lang, John Cameron Unknown Date
No description available.
|
80 |
The impact of HLA-driven escape mutation on viral replicative capacity and immune control in HIV infectionTsai, Ming-Han Chloe January 2017 (has links)
Despite the introduction of antiretroviral therapy, the HIV/HIV epidemic remains an unsolved global health problem. Amongst all the host defence mechanisms, HLA class I molecules have shown the strongest genetic association with delayed disease progression, in particular HLA-B alleles. Numerous studies have shown that the HLAmediated CD8+ T cell responses play a central role in the immune control of HIV. Yet our understanding of HLA-mediated immune control of HIV remains incomplete, even when considering the best-defined epitopes restricted by the protective HLA alleles at a population level. The studies I have conducted and describe herein focus on two well-charaterised protective HLA-B molecules, HLA-B*81:01 and HLA-B*27:05; a third protective molecule, HLA-B*52:01, that has not been well-studied hitherto; and finally the most prevalent HLAB allele in many Asian populations such as Taiwan, HLA-B*40:01, which has an apparently neutral effect on viral replication. This thesis is centred on the Gag-specific immune response, since previous studies have shown the benefits of CD8+ T-cell responses targeting this conserved and immunogenic region of the HIV proteome, in particular the p24 capsid protein. I have investigated here HLA footprints driven by CD8+ T-cell pressure on HIV that are evident in the viral sequences of individuals expressing these HLA molecules. These footprints include novel escape and putative compensatory mutations. The impact of these variants on viral replicative capacity (VRC) and on HIV disease outcome clinical outcomes was examined via fitness assays. These studies identified several escape mutations that effectively cripple HIV. The distinct compensatory pathways available to the virus to mitigate the fitness cost of particular escape mutations were evaluated. In the course of these analyses I have demonstrated the critical influence of the viral backbone, including HIV clade, in combination with particular viral variants, on VRC. Computational modelling analysis has been applied to facilitate understanding of the mechanism by which certain mutants affect the stability of interactions between HLA and viral capsid protein. This thesis offers novel insights into immune control of the key HIV subtypes â B- and C-clade â and of the most severely affected populations â in Africa (South Africa) and Asia (India and Taiwan) â within the global epidemic. This work helps to better define the viral mutation landscape that is essential both for future vaccines designed to corner the virus, and for successful HIV cure strategies.
|
Page generated in 0.0558 seconds